Maximus

US · maximustribe.com

Tesamorelin explained

A powerful growth hormone peptide

This email was sent

May 14, 2026 5:44pm EDT

Is this your brand on Milled? Claim it.

Matte tone:

Get started →

Clinically documented. The data is substantial.

Tesamorelin earned FDA approval in 2010 (branded as EGRIFTA®) for reducing visceral adipose tissue in HIV clients with lipodystrophy. The pivotal trials ran across three multicenter, randomized, double-blind, placebo-controlled Phase 3 studies.

The evidence base is among the strongest of any peptide in this class.

84%

Mean IGF-1 increase in FDA clinical study¹

15%

Visceral fat reduction over 26 weeks, measured by CT scan³

13 days

To reach near-maximum IGF-1 levels with consistent daily dosing¹

Clinical data above is from FDA-approved EGRIFTA® trials. The Maximus Tesamorelin protocol is a compounded medication. Compounded medications are not FDA-approved for safety, efficacy, or quality, and these outcomes have not been established for compounded versions.

Works with your body, not around it

Tesamorelin prompts your body to naturally produce more growth hormone, keeping your regulatory systems intact while delivering powerful results.

🔥

Visceral fat reduction

Targets the dangerous fat around your organs. Clinically documented for this specific outcome.²

✨

Skin, hair, and nails

Beauty from the inside out. Nail growth is typically the first visible sign, usually within 3 months.

⚡

Faster recovery

Shorter downtime between workouts. More effective tissue repair and muscle recovery.

⚙️

Metabolic health

Better insulin sensitivity, improved body composition, and stronger metabolic markers over time.

Timeline

Month 1

Month 2

Month 3

Protocol begins

Five days on, two days off. Most clients skip the weekend injections. IGF-1 starts rising as your body ramps up its own growth hormone production.

First signs appear

Nail growth is typically the first visible indicator. Energy and recovery improvements often reported.

Aesthetic results

Visible body composition changes. Visceral fat reduction becomes measurable. Reassess and optimize with your doctor.

What to know

💧

Some water retention is normal. More powerful than Sermorelin means more effect. Managed with the 5 days on / 2 days off dosing schedule.

🧬

Your doctor will optimize your protocol. Dosage and timing are customized to your biology and goals.

P.S. We now also offer a higher dose of Sermorelin (1mg) at the same great price as Tesamorelin.

Get started →

Important Safety Information

Growth hormone peptides are prescription medications—not appropriate for everyone. Potential side effects include injection site reactions, water retention, joint or muscle pain, tingling or numbness in the extremities, increased hunger, elevated blood sugar, and potential effects on cortisol and prolactin levels. Before any prescription is issued, a licensed healthcare provider will review your health history to determine if treatment is right for you.

References

1. Jain, R., & Choe, S. (2010). Clinical pharmacology and biopharmaceutics review: NDA 22-505 (EGRIFTA/Tesamorelin Acetate). U.S. Food and Drug Administration, Center for Drug Evaluation and Research. NDA 22-505.

2. Fourman, L. T., Czerwonka, N., Feldpausch, M. N., Weiss, J., Mamputu, J. C., Falutz, J., Morin, J., Marsolais, C., Stanley, T. L., & Grinspoon, S. K. (2017). Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV. AIDS (London, England), 31(16), 2253–2259. doi:10.1097/QAD.0000000000001614

3. Falutz, J., Allas, S., Blot, K., Potvin, D., Kotler, D., Somero, M., Berger, D., Brown, S., Richmond, G., Fessel, J., Turner, R., & Grinspoon, S. (2007). Metabolic effects of a growth hormone–releasing factor in patients with HIV. New England Journal of Medicine, 357(23), 2359–2370. doi:10.1056/NEJMoa072375

This email was sent to -.

Disclaimer: For informational purposes only. Not a substitute for medical advice, diagnosis, or treatment. A licensed provider will determine if a prescription is appropriate after evaluation. Individual results vary. Compounded medications are not FDA-approved for safety, efficacy, or quality.

© 2026 Maximus Health, Inc. | 2219 Main Street, Suite 347, Santa Monica, CA 90405
Unsubscribe | Terms | Privacy

Tesamorelin explained

A powerful growth hormone peptide

Recent emails from Maximus